Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus
- PMID: 31100122
- PMCID: PMC7325805
- DOI: 10.1093/infdis/jiz184
Immune Correlates of Diffuse Myocardial Fibrosis and Diastolic Dysfunction Among Aging Women With Human Immunodeficiency Virus
Abstract
Human immunodeficiency virus (HIV) imparts increased heart failure risk to women. Among women with HIV (WHIV), immune pathways relating to heart failure precursors may intimate targets for heart failure prevention strategies. Twenty asymptomatic, antiretroviral-treated WHIV and 14 non-HIV-infected women matched on age and body mass index underwent cardiac magnetic resonance imaging and immune phenotyping. WHIV (vs non-HIV-infected women) exhibited increased myocardial fibrosis (extracellular volume fraction, 0.34 ± 0.06 vs 0.29 ± 0.04; P = .002), reduced diastolic function (diastolic strain rate, 1.10 ± 0.23 s-1 vs 1.39 ± 0.27 s-1; P = .003), and heightened systemic monocyte activation. Among WHIV, soluble CD163 levels correlated with myocardial fibrosis (r = 0.53; P = .02), while circulating inflammatory CD14+CD16+ monocyte CCR2 expression related directly to myocardial fibrosis (r = 0.48; P = .04) and inversely to diastolic function (r = -0.49; P = .03). Clinical Trials Registration. NCT02874703.
Keywords: HIV; diastolic dysfunction; inflammation; myocardial fibrosis; women.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Heart Failure With Preserved Ejection Fraction in Women Living With HIV: Another Inflammatory Comorbidity?J Infect Dis. 2020 Mar 28;221(8):1219-1222. doi: 10.1093/infdis/jiz185. J Infect Dis. 2020. PMID: 31100123 No abstract available.
References
-
- Holloway CJ, Ntusi N, Suttie J, et al. . Comprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patients. Circulation 2013; 128:814–22. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- P30 DK040561/DK/NIDDK NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- R01 HL141132/HL/NHLBI NIH HHS/United States
- R01 HL130539/HL/NHLBI NIH HHS/United States
- R01 HL132786/HL/NHLBI NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- P30 MH092177/MH/NIMH NIH HHS/United States
- P30 AI060354/AI/NIAID NIH HHS/United States
- K08 HD094638/HD/NICHD NIH HHS/United States
- R01 HL137562/HL/NHLBI NIH HHS/United States
- R01 HL140224/HL/NHLBI NIH HHS/United States
- UL1 TR000170/TR/NCATS NIH HHS/United States
- KL2 TR001100/TR/NCATS NIH HHS/United States
- K24 HL113128/HL/NHLBI NIH HHS/United States
- R01 AG062393/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
